PARLIAMENTARY WRITTEN QUESTION
(17 November 2025)
Question Asked
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of designating group B Streptococcus as a notifiable disease.
Asked by:
Andy MacNae (Labour)
Asked by:
Andy MacNae (Labour)
Answer
The UK Health Security Agency (UKHSA) does not recommend adding Group B Streptococcus as a notifiable disease. Existing national surveillance effectively captures Group B Streptococcus infections, monitors trends, and informs antibiotic prescribing policy. The UKHSA has assessed that mandatory notification for Group B Streptococcus would provide no additional public health benefit beyond this.
Answered by:
()
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.